With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

The following is a summary of “Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head ...

Study shows that dietary antigens can suppress small intestine carcinogenesis by activating T-cells through Peyer's patches.

CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies. Receiving CAR-T cell therapies in an outpatient ...

Recent research highlights the significance of universal germline genetic testing (GGT) in uncovering pathogenic germline ...

HMP Global is set to host its first Lymphoma, Leukemia & Myeloma (LL&M) Winter Symposium, a pivotal event for healthcare ...

Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

New updates on the understanding of the link between low-dose ionising radiation and mortality from haematological ...

John Newman, an analyst from Canaccord Genuity, maintained the Buy rating on Adicet Bio (ACET – Research Report). The associated price ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...